2006 -Virinchi Technologies Ltd on Sept 13, 2006, appointed Anil Kumar Pinapala as Chief Executive Officer (CEO) of the Company. 2007 -Company has informed that the Company has designated the following E-mail ID for the purpose of redressal of Investor Complaints. E-mail ID - [email protected] 2010 -The Company has recommended 5% (50 Paise on the face value of Rs.10/- each) dividend for the year 2009-10. 2011 -The Company has recommended 5% dividend (Rs. 0.50 paisa per Equity Share of Rs. 10/- each) for the year 2010-11. 2012 -The Company has recommended 5% dividend (Rs. 0.50 paise per Equity Share of Rs.10/- each) for the year 2011-12. 2013 -Virinchi Acquires Asclepius Consulting to enhance top management band width -Virinchi Technologies acquires majority stake in Asclepius Consulting 2016 -The Name of the Company Changed from "Virinchi Technologies Ltd to Virinchi Ltd". -The Company has launched Virinchi Health Care Mobile App. -Subsidiary of Virinchi Ltd. has opened its first super specialty hospital in Hyderabad. 2017 -Virinchi Limited has been awarded "The Best in Revenue among the IT SMEs for the year 2015-16" by State Govt. of Telangana on the eve of State formation Day -Virinchi awarded as 'The Best Indian IT SME for the year 2015-16' by HYSEA. -Virinchi Hospitals received The Times Health Care 2017 Award as the "Emerging hospital of the year in multi-Specialty Hospital category". -Virinchi signs multi-year contract for its product. -"Virinchi Signs-up with one more leading Alternative Financing Lender in USA for providing its product 'Qfund on Cloud' on an annuity model". 2018 -Virinchi starts work on phase 2 of Banjara Hills facility. -Virinchi signs multi-product contract with Advance America. 2019 -Product Launch-Vcard - India'S First UPI Based Credit Card. 2022 -The Company has issued Bonus Shares in the Ratio of 1:1. |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article